Virtus Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,148
Closed -$137K – 254
2023
Q2
$137K Hold
2,148
– – 0.09% 221
2023
Q1
$149K Hold
2,148
– – 0.1% 216
2022
Q4
$155K Hold
2,148
– – 0.1% 224
2022
Q3
$153K Buy
+2,148
New +$156K 0.07% 238
2018
Q1
– Sell
-6,880
Closed -$422K – 69
2017
Q4
$422K Sell
6,880
-369
-5% -$23.1K 0.05% 318
2017
Q3
$462K Sell
7,249
-864
-11% -$50.4K 0.05% 324
2017
Q2
$452K Sell
8,113
-1,581
-16% -$86K 0.04% 335
2017
Q1
$527K Buy
+9,694
New +$532K 0.05% 319
2016
Q4
– Sell
-55,687
Closed -$3M – 474
2016
Q3
$3M Buy
+55,687
New +$3.58M 0.19% 170

Other funds holding BMY

Virtus Investment Advisers's BMY Position: Q3 2023 in Review

Virtus Investment Advisers sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 2,148 shares — an estimated $137K sold.

Virtus Investment Advisers first reported a position in BMY in Q3 2016 and held it in 9 quarters. The position peaked at $3M in Q3 2016. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Virtus Investment Advisers reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Virtus Investment Advisers sold 2,148 Bristol-Myers Squibb shares in Q3 2023, an estimated $137K.
  • Virtus Investment Advisers first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 9 quarters.
  • Virtus Investment Advisers's Bristol-Myers Squibb position peaked at $3M in Q3 2016.
  • 2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Virtus Investment Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.